Advanced search
Publication Cover
International Journal of Chronic Obstructive Pulmonary Disease Volume 14, 2019 - Issue
Submit an article Journal homepage
93
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Clinical Outcomes Of Using Nebulized Budesonide As The Initial Treatment For Acute Exacerbations Of Chronic Obstructive Pulmonary Disease: A Post-Hoc Analysis

Jin-Ping Zheng1 State Key Laboratory of Respiratory Disease, National Clinical Research Center, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University, Guangzhou, People’s Republic of China
,
Jing Zhang2 Department of Respiratory Medicine, Peking University Third Hospital, Beijing, People’s Republic of China
,
Li-Jun Ma3 Department of Respiratory Medicine, Henan Provincial People’s Hospital, Henan, People’s Republic of China
,
Ping Chen4 Department of Internal Medicine, The Second Xiangya Hospital, Hunan, People’s Republic of China
,
Mao Huang5 Jiangsu Province Hospital, Jiangsu, People’s Republic of China
,
Xue-Mei Ou6 Department of Respiratory Medicine, West China Hospital, Chengdu, People’s Republic of China
,
Zi-Wen Zhao7 Department of Respiratory Medicine, Guangzhou First People’s Hospital, Guangzhou, People’s Republic of China
,
Shu-Juan Jiang8 Department of Respiratory Medicine, Shandong Provincial Hospital, Shandong, People’s Republic of China
,
Jie Cao9 Department of Respiratory Medicine, Tianjin Medical University General Hospital, Tianjin, People’s Republic of China
&
Wanzhen Yao2 Department of Respiratory Medicine, Peking University Third Hospital, Beijing, People’s Republic of ChinaCorrespondence[email protected]
 show all
Pages 2725-2731 | Published online: 29 Nov 2019

References

  • Kiser TH, Vandivier RW. Severe acute exacerbations of chronic obstructive pulmonary disease: does the dosage of corticosteroids and type of antibiotic matter? Curr Opin Pulm Med. 2015;21:142–148. doi:10.1097/MCP.000000000000014225575365
  • Ding Z, Li X, Lu Y, et al. A randomized, controlled multicentric study of inhaled budesonide and intravenous methylprednisolone in the treatment on acute exacerbation of chronic obstructive pulmonary disease. Respir Med. 2016;121:39–47. doi:10.1016/j.rmed.2016.10.01327888990
  • Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of COPD; 2016 Available from: http://goldccopd.org/global-strategy-disgnosis-management-preventioin-copd-2016/. Accessed 91, 2016.
  • Bishwakarma R, Zhang W, Kuo YF, et al. Long-acting bronchodilators with or without inhaled corticosteroids and 30-day readmission in patients hospitalized for COPD. Int J Chron Obstruct Pulmon Dis. 2017;12:477–486. doi:10.2147/COPD.S12235428203071
  • Bourbeau J, Sedeno MF, Metz K, et al. Early COPD exacerbation treatment with combination of ICS and LABA for patients presenting with mild-to-moderate worsening of dyspnea. COPD. 2016;13:439–447. doi:10.3109/15412555.2015.110143526752024
  • Chow L, Parulekar AD, Hanania NA. Hospital management of acute exacerbations of chronic obstructive pulmonary disease. J Hosp Med. 2015;10:328–339. doi:10.1002/jhm.233425820201
  • Kiser TH, Allen RR, Valuck RJ, et al. Outcomes associated with corticosteroid dosage in critically ill patients with acute exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2014;189:1052–1064. doi:10.1164/rccm.201401-0058OC24617842
  • Walters JA, Tan DJ, White CJ, et al. Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2014;9:CD001288. doi:10.1002/14651858cd001288.pub4
  • Kiser TH, Sevransky JE, Krishnan JA, et al. A survey of corticosteroid dosing for exacerbations of chronic obstructive pulmonary disease requiring assisted ventilation. Chronic Obstr Pulm Dis. 2017;4:186–193. doi:10.15326/jcopdf.4.3.2016.016828848930
  • Maltais F, Ostinelli J, Bourbeau J, et al. Comparison of nebulized budesonide and oral prednisolone with placebo in the treatment of acute exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2002;165:698–703. doi:10.1164/ajrccm.165.5.210909311874817
  • Mirici A, Meral M, Akgun M. Comparison of the efficacy of nebulized budesonide with parenteral corticosteroids in the treatment of acute exacerbations of chronic obstructive pulmonary disease. Clin Drug Invest. 2003;23:55–62. doi:10.2165/00044011-200323010-00007
  • Gunen H, Hacievliyagil SS, Yetkin O, et al. The role of nebulized budesonide in the treatment of exacerbations of COPD. Eur Respir J. 2007;29:660. doi:10.1183/09031936.0007350617251232
  • Sun X, He Z, Zhang J, et al. Compare the efficacy of inhaled budesonide and systemic methylprednisolone on systemic inflammation of AECOPD. Pulm Pharmacol Ther. 2015;31:111–116. doi:10.1016/j.pupt.2014.09.00425281894
  • Zhang J, Zheng J, Huang K, et al. Use of glucocorticoids in patients with COPD exacerbations in China: a retrospective observational study. Ther Adv Respir Dis. 2018;12:1–7. doi:10.1177/1753466618769514
  • Zhai Y, Zhang H, Sun T, et al. Comparative efficacies of inhaled corticosteroids and systemic corticosteroids in treatment of chronic obstructive pulmonary disease exacerbations: a systematic review and meta-analysis. J Aerosol Med Pulm Drug Deliv. 2017;30(5):289–298. doi:10.1089/jamp.2016.135328300474

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.